Skip to main content

Table 1 The demographical characteristics and smoking habits of participants

From: A comparison of the efficacy of varenicline and bupropion and an evaluation of the effect of the medications in the context of the smoking cessation programme

Variable Varenicline (n = 244) Bupropion (n = 161) p*
n % n %
Gender Male (n = 334) 194 79.5 140 87.0 0.054
Female (n = 71) 50 20.5 21 13.0
Age Groups 20–29 (n = 111) 74 30.3 37 23.0 0.267
30–39 (n = 184) 106 43.4 78 48.4
≥40 (n = 110) 64 26.2 46 28.6
Marital Status Married (n = 329) 191 78.3 138 85.7 0.061
Not Married (n = 76) 53 21.7 23 14.3
Educational Status Primary- Secondary 45 18.4 31 19.3 0.775
High School 101 41.4 71 44.1
College + a 98 40.2 59 36.6
Alcohol Consumption Status Yes (n = 63) 37 15.2 26 16.163 0.789
No (n = 342) 207 84.8 135 83.9
Social support Yes (n = 241) 169 69.3 75 65.2 0.394
No (n = 161) 75 30.7 86 34.8
The amount of cigarettes smoked per day in the initial presentation 1–10 pcs 29 11.9 5 3.1 0.004
11–20 pcs 99 40.6 86 53.4
21–30 pcs 79 53.4 43 26.7
≥31 pcs 37 45.7 27 16.8
Previous quitting trial Yes (n = 272) 167 68.4 105 65.2 0.499
No (n = 133) 77 31.6 56 34.8
Concerns about the harmful effects of smoking No (n = 24) 16 6.6 8 5.0 0.532
Little (n = 69) 45 18.4 24 14.9
High (n = 170) 96 39.3 74 46.0
Very High (n = 142) 87 35.7 55 34.2
Mean Fagerstrom Score 6.34 ± 2.38 6.23 ± 2.49 0.655**
The amount of cigarettes/day in the initial presentation 22.78 ± 10.11 23.39 ± 9.13 0.540
Mean Age 34.8 ± 7.61 35.9 ± 7.78 0.124
Mean age of start to begin smoking 17.80 ± 4.26 17.60 ± 4.35 0.635
Mean Body Mass Index 25.46 ± 3.80 26.11 ± 3.59 0.082
  1. *Chi square test, **Independent sample t test (in evaluation of mean values)
  2. aCollege graduate or bachelor’s degree